Lebenthal Global Advisors, LLC Astrazeneca PLC Transaction History
Lebenthal Global Advisors, LLC
- $617 Million
- Q4 2025
A detailed history of Lebenthal Global Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Lebenthal Global Advisors, LLC holds 13,279 shares of AZN stock, worth $1.19 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
13,279Holding current value
$1.19 Million% of portfolio
0.19%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,548Shares Held
503MCall Options Held
5.54MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...